Furthermore, mutations in the cytosolic 5′-nucleotidase II gene NT5C2 lead to proteins with increased nucleotides activity and result in increased nucleoside-analog metabolism and 6-mercaptopurine resistance in chALL (103 T-ALL and 35 BCP-ALL) (139). This evidence concerns the gene NT5C2 and acute lymphoblastic leukemia.